about
CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexesVprBP has intrinsic kinase activity targeting histone H2A and represses gene transcriptionEpigenetics meets radiation biology as a new approach in cancer treatmentProtective effect of genistein on radiation-induced intestinal injury in tumor bearing mice.Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy.Mono-allelic retrotransposon insertion addresses epigenetic transcriptional repression in human genome.The combination of sorafenib and radiation preferentially inhibits breast cancer stem cells by suppressing HIF-1α expressionIsolation and characterization of a novel H1.2 complex that acts as a repressor of p53-mediated transcription.The histone variant MacroH2A regulates Ca(2+) influx through TRPC3 and TRPC6 channels.Gene dysregulation by histone variant H2A.Z in bladder cancer.Cooperative action of TIP48 and TIP49 in H2A.Z exchange catalyzed by acetylation of nucleosomal H2A.Low-dose-rate radiation exposure leads to testicular damage with decreases in DNMT1 and HDAC1 in the murine testis.Attenuating effects of granulocyte-colony stimulating factor (G-CSF) in radiation induced intestinal injury in mice.Genistein mitigates radiation-induced testicular injury.Histone demethylase JMJD2B-mediated cell proliferation regulated by hypoxia and radiation in gastric cancer cell.Cell-penetrating H4 tail peptides potentiate p53-mediated transactivation via inhibition of G9a and HDAC1.Novel anti-cancer role of naphthazarin in human gastric cancer cells.FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16.p53 requires an intact C-terminal domain for DNA binding and transactivation.Activation of de novo GSH synthesis pathway in mouse spleen after long term low-dose γ-ray irradiation.Purification and characterization of cellular proteins associated with histone H4 tails.EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.
P50
Q24336306-64859C05-5832-4A63-B9DE-C7CF936011BBQ24338707-0A9D6F99-5592-469A-ABC1-047F5CCB6767Q27014984-898CC166-505D-4031-8248-614D2E8618C4Q34721939-A55D00B2-570D-46E0-AA51-5697B1FED108Q35198394-9F8243B5-2ED6-4EA1-9312-41BA18AB6A1BQ35861657-CABCFA97-5583-45BD-8587-9A8D947BAEDAQ36684583-CFD9CCB3-608C-4F3E-AF0F-9E6FC42ED146Q36727277-E94A0C06-A989-49B9-B08A-5AC64EC90E0BQ37275743-73313592-CFBD-4B5A-91A5-DA7A93EC8CFCQ37369056-066D0E6B-AAE2-46CE-9C9B-9BD7C4C03A88Q37393506-1C7298D2-7D2A-4117-8295-12100BD4B9E4Q37450643-ADFF0EBE-D505-4AA9-8131-54431A569626Q38461609-1A236B37-0A76-4746-8800-FB44F75B7C5BQ38467500-9565B4CA-AE4F-4E2C-A7D3-321819896383Q39263646-1730D4E0-6B14-4648-8AA4-0CD858A467A4Q39321805-BEEBCBE0-D4CA-4F8A-B369-BBFE7E497538Q39476823-0454E69E-3C5E-45CB-9DDB-93A070B3D95DQ39992783-0D9DC6B5-8446-417F-938F-5FF037CC876BQ40715545-09BE5D26-0159-4670-8F30-5393F8F5E75EQ43908826-4DCB992E-0C74-4E7B-BE9E-2F57D3F382AFQ46132121-37AFF8DD-0F61-44AD-A0D5-9BB26C65BE49Q47214177-E6C2292A-E17A-46B4-AD3D-B1E5E03F5EDF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kyu Heo
@ast
Kyu Heo
@en
Kyu Heo
@es
Kyu Heo
@nl
Kyu Heo
@sl
type
label
Kyu Heo
@ast
Kyu Heo
@en
Kyu Heo
@es
Kyu Heo
@nl
Kyu Heo
@sl
prefLabel
Kyu Heo
@ast
Kyu Heo
@en
Kyu Heo
@es
Kyu Heo
@nl
Kyu Heo
@sl
P106
P1153
14119813000
P2038
P21
P2381
P31
P496
0000-0001-8833-4731